The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s disease

by Diana L. Price, Maya A. Koike, Asma Khan, Wolfgang Wrasidlo, Edward Rockenstein, Eliezer Masliah, Douglas Bonhaus
Published 2018-11-01

Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicity.

by Diana L Price, Edward Rockenstein, Kiren Ubhi, Van Phung, Natalie MacLean-Lewis, David Askay, Anna Cartier, Brian Spencer, Christina Patrick, Paula Desplats, Mark H Ellisman, Eliezer Masliah
Published 2010-11-01